NCT04615572View on ClinicalTrials.gov

Screening to Improve Survival in AL Amyloidosis

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

August 28, 2020

Primary Completion Date

July 6, 2023

Study Completion Date

July 6, 2023

Conditions
Smoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance
Trial Locations (6)

10032

Columbia University Irving Medical Center, New York

27599

UNC Lineberger Comprehensive Cancer Center, Chapel Hill

33136

University of Miami Sylvester Comprehensive Cancer Center, Miami

92868

University of California, Irvine Health Chao Family Comprehensive Cancer Center, Orange

94143

University of California, San Francisco, San Francisco

02111

Tufts Medical Center, Boston

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Tufts Medical Center

OTHER

NCT04615572 - Screening to Improve Survival in AL Amyloidosis | Biotech Hunter | Biotech Hunter